Nobacz

About Nobacz

Nobacz Healthcare is a University of Cambridge spin-out company, founded in 2019 by Dr. Jonathan Powell and Dr. Nuno Faria, that develops antibiotic-free wound and lesion care products for livestock and horses. The founders' research at the University of Cambridge's Department of Veterinary Medicine focused on how the body naturally utilizes mineral structures, which led to the creation of Nobacz's patented 'liquid bandage' technology. This technology was initially developed to address digital dermatitis in cows, a disease that is both painful for the animals and costly for farmers.

The company's core product is a robust, flexible, and waterproof coating that can be applied as a gel, dip, or spray. Unlike traditional treatments that involve antibiotics and cloth bandages, which can be ineffective in agricultural settings, Nobacz's solution creates an immediate protective barrier. This barrier seals out slurry and bacteria, allowing wounds to heal without the risk of infection, even in harsh farm environments. The products are made from food and feed-grade ingredients, are biodegradable, and are safe for the food chain. Key products include NoBacz Bovine, NoBacz Navel, and Ambugreen, which are designed for use on hooves, navels, udders, and other areas.

Nobacz operates in the veterinary healthcare market, serving farmers and veterinarians. The business model is centered on the sale of its patented wound care products through various distribution channels. The company has established partnerships and is active in international markets, including the UK, Ireland, Europe, New Zealand, the US, and Australia. Nobacz has secured significant funding to support its global commercialization and product development efforts, including a £4.8 million funding round in late 2025. The company is also exploring the potential application of its technology for human wound care.